相关实验视频
Updated: Mar 17, 2026

05:05
Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
12.8K
微脉冲透膜循环光凝固用于管理多种类型的青光眼:一个多中心短期现实研究
Núbia Vanessa Dos Anjos Lima1, Nara Lidia Vieira Lopes2, Heloisa Andrade Maestrini3
1Department of Ophthalmology, UniCeub - Brasília, Brasília, DF, Brazil.
Clinical ophthalmology (Auckland, N.Z.)
|March 16, 2026
概括
微脉冲横环光凝血 (MP-TSCPC) 有效降低眼内压力 (IOP) 并减少各种类型的青光眼的药物需求. 这种安全的程序在12个月内显示出一致的IOP控制,无论患者的病史如何.
科学领域:
- 眼科医生 眼科 眼科
- 青光眼治疗方法 青光眼治疗方法
- 手术方面的创新.
背景情况:
- 绿眼的管理需要有效的策略来降低眼内压力 (IOP) 并防止视力丧失.
- 微脉冲穿细胞循环光凝血 (MP-TSCPC) 是一种新兴的治疗选择,用于各种类型的青光眼.
- 评估MP-TSCPC的实际有效性和安全性对于临床决策至关重要.
研究的目的:
- 评估MP-TSCPC在减少多种青光眼患者群体内IOP和药物负担方面的安全性和有效性.
- 调查青光眼的亚型,先前的眼部手术和并发症对MP-TSCPC治疗结果的影响.
- 分析MP-TSCPC后的并发症率和视力敏度变化.
主要方法:
- 一个回顾性多中心研究,涉及101只用MP-TSCPC治疗的眼睛,使用IRIDEX Cyclo G6 MP3激光.
- 对所有参与者保持了至少12个月的随访期.
- 主要结局包括内血压降低和低血压药物使用的变化;成功被定义为≥20%的内血压降低或内血压6-21mmHg.
主要成果:
- 在12个月内,MP-TSCPC显著降低了从26.19 ± 6.77 mmHg的平均内血压,从14.40 ± 6.10 mmHg降低到14.40 ± 6.10 mmHg (大约为1.9 ± 0.3 mmHg). -45%的减少;p<0.0001).
- 不同青光眼亚型,先前的手术史或并发症之间没有观察到治疗成功的显著差异 (p > 0.05).
- 严重的并发症是罕见的,大多数患者的视力敏度稳定,没有发病或低视力.
结论:
- MP-TSCPC提供了一种安全有效的方法,用于持续控制IOP和减少药物治疗在广泛的青光眼患者中.
- 该程序是对耐火性和功能性玻璃眼病例的多功能替代方案.
- 现实世界的数据支持MP-TSCPC的实用性,尽管需要长期的随访来评估长期的通用性.
相关概念视频
Angle Closure Glaucoma: Treatment
1.5K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.5K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Glaucoma: Overview
1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
Ophthalmic Drug Delivery Systems
156
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
156

